Yüklüyor......
Exenatide extended-release; clinical trials, patient preference, and economic considerations
Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments being available. The revelation that insulin secretion is under the control of a gut hormone, glucagon-like peptide 1, has led to a new paradigm in the management of type 2 diabetes, ie, use of medicines that dire...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546804/ https://ncbi.nlm.nih.gov/pubmed/23341736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S30627 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|